The Centers for Disease Control and Prevention (CDC) of the United States has lifted 11-day ban on Johnson & Johnson (J&J) Covid-19 jab. However a warning tag will be attached with the vaccine informing of potential rare blood clots.
Fifteen vaccine recipients suffered from a dangerous blood clot out of nearly eight million given the jab.
This week, Europe’s drug regulator also ended restrictions on the J&J vaccine.
European regulators this month also linked similar, highly unusual blood clots to the AstraZeneca Covid-19 shot, but found the benefits of the drug outweighed any risks.
On Friday afternoon, the CDC and Food and Drug Administration swiftly followed the recommendation of the CDC advisory panel after it voted 10-4 to continue rolling out the vaccine for people 18 years of age and older in line with its original authorization.
The decision means at least 10 million doses of the J&J vaccine, shipped from the company’s factory in the Netherlands, can be deployed across the US immediately.
The health officials on Friday identified nine more cases of the blood clots, adding to six cases already identified since regulators first approved the jab as safe and effective in February.
All were women, most under the age of 50. Three died and seven remain in hospital.
About a dozen of the cases affected women aged 30-39. Seven of the women were obese, two had high blood pressure, and two were using oral contraceptives, according to health officials.
CDC officials who presented the data on Friday said a few cases of blood clots in men were being reviewed, too.
The officials also said it was important for women be told about the potential risks of the vaccine so they could decide whether to seek alternatives.
Symptoms can arise within three weeks of vaccination and include acute headaches, shortness of breath, and leg and abdominal pain.
US health officials are warning doctors that heparin, a common treatment for blood clots, can worsen the vaccine-linked condition.
